(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-amino-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-bromo-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-2-chloro-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-chloro-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(2-oxopropyl)-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]benzoic acid

C146H123BrCl7N31O17 — CID 159374754

About (E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-amino-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-bromo-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-2-chloro-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-chloro-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(2-oxopropyl)-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]benzoic acid

(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-amino-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-bromo-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-2-chloro-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-chloro-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(2-oxopropyl)-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]benzoic acid (PubChem CID 159374754) has the molecular formula C146H123BrCl7N31O17 and a molecular weight of 2911.86 g/mol. Its IUPAC name is (E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-amino-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-bromo-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-2-chloro-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-chloro-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(2-oxopropyl)-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]benzoic acid.

Molecular Properties

• Compound Name: (E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-amino-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-bromo-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-2-chloro-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-chloro-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(2-oxopropyl)-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]benzoic acid
• PubChem CID: 159374754
• Molecular Formula: C146H123BrCl7N31O17
• Molecular Weight: 2911.86 g/mol
• Exact Mass: 2905.67
• IUPAC Name: (E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-amino-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-bromo-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-2-chloro-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-chloro-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(2-oxopropyl)-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]benzoic acid
• SMILES: CC(=O)Cc1cnc2c(c1)C(C(=O)Cc1ccc(C(=O)O)cc1)N(C(=O)/C=C/c1cc(Cl)ccc1-n1cnnn1)CC2.CC(=O)c1ccc(CC(=O)C2c3cc(Br)cnc3CCN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1.CC(=O)c1ccc(CC(=O)C2c3cc(Cl)cnc3C(C)(C)CN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1.CC(=O)c1ccc(CC(=O)C2c3cc(N)cnc3C(C)(C)CN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1.CC(=O)c1ccc(CC(=O)C2c3ccc(Cl)nc3CCN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1
• InChI: InChI=1S/C30H26Cl2N6O3.C30H28ClN7O3.C30H25ClN6O5.C28H22BrClN6O3.C28H22Cl2N6O3/c2*1-18(39)20-6-4-19(5-7-20)12-26(40)28-24-14-23(32)15-33-29(24)30(2,3)16-37(28)27(41)11-8-21-13-22(31)9-10-25(21)38-17-34-35-36-38;1-18(38)12-20-13-24-25(32-16-20)10-11-36(29(24)27(39)14-19-2-4-21(5-3-19)30(41)42)28(40)9-6-22-15-23(31)7-8-26(22)37-17-33-34-35-37;1-17(37)19-4-2-18(3-5-19)12-26(38)28-23-14-21(29)15-31-24(23)10-11-35(28)27(39)9-6-20-13-22(30)7-8-25(20)36-16-32-33-34-36;1-17(37)19-4-2-18(3-5-19)14-25(38)28-22-8-10-26(30)32-23(22)12-13-35(28)27(39)11-6-20-15-21(29)7-9-24(20)36-16-31-33-34-36/h4-11,13-15,17,28H,12,16H2,1-3H3;4-11,13-15,17,28H,12,16,32H2,1-3H3;2-9,13,15-17,29H,10-12,14H2,1H3,(H,41,42);2-9,13-16,28H,10-12H2,1H3;2-11,15-16,28H,12-14H2,1H3/b2*11-8+;2*9-6+;11-6+
• InChIKey: LKEBIMNBAMTJSW-VAERJROVSA-N
• XLogP: 22.07
• TPSA: 618.02 Ų
• H-Bond Donors: 2
• H-Bond Acceptors: 42
• Rotatable Bonds: 37
• Heavy Atoms: 202
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2911.86
LogP ≤ 5	22.07
H-Bond Donors ≤ 5	2
H-Bond Acceptors ≤ 10	42

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of (E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-amino-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-bromo-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-2-chloro-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-chloro-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(2-oxopropyl)-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]benzoic acid?

The IUPAC name of (E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-amino-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-bromo-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-2-chloro-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-chloro-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(2-oxopropyl)-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]benzoic acid (CID 159374754) is (E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-amino-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-bromo-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-2-chloro-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-chloro-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(2-oxopropyl)-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]benzoic acid.

What is the SMILES notation for (E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-amino-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-bromo-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-2-chloro-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-chloro-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(2-oxopropyl)-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]benzoic acid?

The canonical SMILES for (E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-amino-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-bromo-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-2-chloro-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-chloro-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(2-oxopropyl)-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]benzoic acid is CC(=O)Cc1cnc2c(c1)C(C(=O)Cc1ccc(C(=O)O)cc1)N(C(=O)/C=C/c1cc(Cl)ccc1-n1cnnn1)CC2.CC(=O)c1ccc(CC(=O)C2c3cc(Br)cnc3CCN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1.CC(=O)c1ccc(CC(=O)C2c3cc(Cl)cnc3C(C)(C)CN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1.CC(=O)c1ccc(CC(=O)C2c3cc(N)cnc3C(C)(C)CN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1.CC(=O)c1ccc(CC(=O)C2c3ccc(Cl)nc3CCN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1.

What is the InChIKey of (E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-amino-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-bromo-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-2-chloro-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-chloro-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(2-oxopropyl)-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]benzoic acid?

The InChIKey is LKEBIMNBAMTJSW-VAERJROVSA-N. The full InChI is InChI=1S/C30H26Cl2N6O3.C30H28ClN7O3.C30H25ClN6O5.C28H22BrClN6O3.C28H22Cl2N6O3/c2*1-18(39)20-6-4-19(5-7-20)12-26(40)28-24-14-23(32)15-33-29(24)30(2,3)16-37(28)27(41)11-8-21-13-22(31)9-10-25(21)38-17-34-35-36-38;1-18(38)12-20-13-24-25(32-16-20)10-11-36(29(24)27(39)14-19-2-4-21(5-3-19)30(41)42)28(40)9-6-22-15-23(31)7-8-26(22)37-17-33-34-35-37;1-17(37)19-4-2-18(3-5-19)12-26(38)28-23-14-21(29)15-31-24(23)10-11-35(28)27(39)9-6-20-13-22(30)7-8-25(20)36-16-32-33-34-36;1-17(37)19-4-2-18(3-5-19)14-25(38)28-22-8-10-26(30)32-23(22)12-13-35(28)27(39)11-6-20-15-21(29)7-9-24(20)36-16-31-33-34-36/h4-11,13-15,17,28H,12,16H2,1-3H3;4-11,13-15,17,28H,12,16,32H2,1-3H3;2-9,13,15-17,29H,10-12,14H2,1H3,(H,41,42);2-9,13-16,28H,10-12H2,1H3;2-11,15-16,28H,12-14H2,1H3/b2*11-8+;2*9-6+;11-6+.

What are the key properties of (E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-amino-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-bromo-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-2-chloro-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-chloro-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(2-oxopropyl)-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]benzoic acid?

(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-amino-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-bromo-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-2-chloro-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-chloro-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(2-oxopropyl)-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]benzoic acid has a molecular weight of 2911.86 g/mol, XLogP of 22.07, 37 rotatable bonds, 2 hydrogen bond donors, and 42 hydrogen bond acceptors.

Where does this data come from?

All data for (E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-amino-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-bromo-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-2-chloro-7,8-dihydro-5H-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-1-[5-[2-(4-acetylphenyl)acetyl]-3-chloro-8,8-dimethyl-5,7-dihydro-1,6-naphthyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;4-[2-[6-[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-3-(2-oxopropyl)-7,8-dihydro-5H-1,6-naphthyridin-5-yl]-2-oxoethyl]benzoic acid is sourced from PubChem (CID 159374754), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).